Grace Therapeutics GRCE
NASDAQ GRCE
$1.91 -0.06 (-3.05%)
As of: Oct 22, 2026 · 10:38 AM EDT

Grace Therapeutics (GRCE) Deferred Taxes (2023 - 2026)

Updated

Grace Therapeutics' Deferred Taxes came in at -$1.7 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with -$1.02 million a year earlier.

Analysis

Grace Therapeutics (GRCE) Deferred Taxes (2023 - 2026) Analysis & Trends

Going back to fiscal Q3 2024, Grace Therapeutics' Deferred Taxes data covers 7 quarters.

  • Going back by fiscal year, Deferred Taxes was -$3.2 million in FY2025, -$1.83 million in FY2024, -$9.54 million in FY2023 and -$648,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,162.99 Bn 1,131.58 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 633.71 Bn 552.23 Bn 17.26 Bn -479.00 Mn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn -195.00 Mn
4 Merck 376.48 Bn 330.86 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn -
6 Astrazeneca 267.02 Bn 240.70 Bn 12.86 Bn -
7 Amgen 240.85 Bn 196.25 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 193.39 Bn 167.58 Bn 6.22 Bn -587.00 Mn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -1.32 Bn
10 Grace Therapeutics 32.99 Mn -33.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.70 Mn
Mar 31, 2025 -1.02 Mn
Dec 31, 2024 -605,000.00
Sep 30, 2024 -852,000.00
Jun 30, 2024 -724,000.00
Mar 31, 2024 -891,000.00
Dec 31, 2023 -208,000.00
API Access

Grace Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=GRCE&period=max&api_key=YOUR_API_KEY